Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology
Elias Zerhouni Nominated for NIH Director; Richard Carmona For Surgeon General
NCI Advisors Approve New Grant Program In Bone Metastasis
NIH Seeks Comment On Reorg Plan For Oncology Study Sections
Youth Smoking Begins To Decline, NCI Says
Funding Opportunities.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ









